A trial of flutiform in asthma patients in China
Phase of Trial: Phase III
Latest Information Update: 21 Mar 2017
At a glance
- Drugs Formoterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 21 Mar 2017 According to a Vectura media release, this study is planned to initiate in H2 2017.
- 02 Dec 2016 New trial record
- 22 Nov 2016 According to a Vectura Group plc media release, Mundipharma plans to start this trial once approval is obtianed from the Chinese Food and Drug Administration (CFDA).